Grant: Discovery Grants Program - Individual
University of British Columbia
$39,500.00
Implantable wireless microdevices for pinpoint diagnosis and therapy
EF 2007-08
Résumé
In this research, we will investigate implantable micro devices and MEMS (micro-electro-mechanical systems) for wireless diagnoses and treatments of localized lesions in the body. The technologies developed are expected to provide minimally invasive means to effectively fight chronic or life-threatening diseases, e.g., vascular disorders involving stenosis (narrowing) or aneurysm in coronary or cerebral arteries and tumorous diseases including cancers. The research will focus on advanced drug delivery technologies that allow implant devices to release multiple pharmacologic agents with doses and timings that can be flexibly modified after the implantation depending on patients' physical conditions. This goal will be approached by developing implantable micro transducers that are wirelessly controlled to switch and regulate the release of drugs with no battery. Another target of this research is telemetric monitoring of biological parameters. One important focus is cardiovascular stents that are integrated with micro pressure/flow sensors to provide advance notice of re-narrowing, a common failure mechanism for stents. These stents will be developed to serve as a radiofrequency passive antenna to perform the task wirelessly. The technologies obtained through these efforts will offer an opportunity to realize "smart" stents that have both the diagnostic and therapeutic functions, as in blood flow sensing and thrombolytic agent release, for feedback operations. The device fabrication in this effort will exploit non-silicon micromachining technologies such as micro-electro-discharge machining and micro mechanical processing to make a variety of high-performance bulk materials including biocompatible metals and polymers available for the design and fabrication of the devices. This approach will facilitate the acquisition of inherent biocompatibility and robustness of the devices, allowing them to directly interact with biological tissues and fluids and achieve higher performance.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
328944-2006
Name nom
Takahata, Kenichi
Department département
Electrical and Computer Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
39500
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
335
Committee name en
Electromag. & Electr. Systems (H)
Committee name fr
Électromagn. et syst. électr. (H)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2500
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Electrical and electronic engineering
Research subject fr
Génie électrique et électronique
Partie
2
Nb partie
5
Application title
Implantable wireless microdevices for pinpoint diagnosis and therapy
Keyword
NA
Application summary
In this research, we will investigate implantable micro devices and MEMS (micro-electro-mechanical systems) for wireless diagnoses and treatments of localized lesions in the body. The technologies developed are expected to provide minimally invasive means to effectively fight chronic or life-threatening diseases, e.g., vascular disorders involving stenosis (narrowing) or aneurysm in coronary or cerebral arteries and tumorous diseases including cancers. The research will focus on advanced drug delivery technologies that allow implant devices to release multiple pharmacologic agents with doses and timings that can be flexibly modified after the implantation depending on patients' physical conditions. This goal will be approached by developing implantable micro transducers that are wirelessly controlled to switch and regulate the release of drugs with no battery. Another target of this research is telemetric monitoring of biological parameters. One important focus is cardiovascular stents that are integrated with micro pressure/flow sensors to provide advance notice of re-narrowing, a common failure mechanism for stents. These stents will be developed to serve as a radiofrequency passive antenna to perform the task wirelessly. The technologies obtained through these efforts will offer an opportunity to realize "smart" stents that have both the diagnostic and therapeutic functions, as in blood flow sensing and thrombolytic agent release, for feedback operations. The device fabrication in this effort will exploit non-silicon micromachining technologies such as micro-electro-discharge machining and micro mechanical processing to make a variety of high-performance bulk materials including biocompatible metals and polymers available for the design and fabrication of the devices. This approach will facilitate the acquisition of inherent biocompatibility and robustness of the devices, allowing them to directly interact with biological tissues and fluids and achieve higher performance.